Renaissance Capital logo

IPO News & Commentary

Get the latest insights on new stocks

Cancer and HBV biotech Ascentage Pharma files for a $100 million US IPO

Ascentage Pharma logo

Ascentage Pharma, a clinical-stage Chinese biotech developing novel therapies for cancer, hepatitis B, and age-related diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Ascentage's lead drug olverembatinib, a...read more

Space flight equipment provider Helio files and sets terms for $15 million NYSE American uplisting

Helio Corporation logo

Helio Corporation, which designs, assembles, and tests space flight equipment, filed on Friday with the SEC to raise up to $15 million in an NYSE American uplisting. It is currently listed on the OTC Pink under the symbol HLEO The Berkeley, CA-based company...read more

Chinese skincare product company Park Ha prices US IPO at $4, the low end of the range

Park Ha Biological Technology logo

Park Ha Biological Technology, which sells skincare and cosmetic products in China, raised $4.8 million by offering 1.2 million shares at $4, the low end of the range of $4 to $6. ...read more

IPO News By Industry

Be the in-house IPO Expert

Our clients are focused on catalyzing growth and creating value.

Not scouring the web for IPO data.

Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.